Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Broders

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 21, 2002
Hyperphage. Improving antibody presentation in phage displayOlaf Broders, Frank Breitling, Stefan Dübel
Methods in Molecular Medicine|February 13, 2004
Cloning single-chain antibody fragments (scFv) from hybridoma cellsLars Toleikis, Olaf Broders, Stefan Dübel
Biotechnology & Genetic Engineering Reviews|March 5, 2004
Therapeutic antibodies and antibody fusion proteinsPetra Rohrbach, Olaf Broders, Lars Toleikis, et al.
Bioanalysis|May 1, 2020
Novel bioanalytical method for the characterization of the immune response directed against a bispecific F(ab) fragmentOlaf Broders, Uwe Wessels, Markus Zadak, et al.
Molecular Pharmaceutics|May 20, 2021
Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care FormatsPaulina Jakubiak, Rubén Alvarez-Sánchez, Matthias Fueth, et al.
Frontiers in Immunology|May 4, 2026
Translational strategy to support the first-in-human study of a TCR-like T cell bispecific with an <i>in vitro</i>-based safety approachAngelique Augustin, Blandine Avignon, Christophe Boetsch, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|December 21, 2002
Hyperphage. Improving antibody presentation in phage displayOlaf Broders, Frank Breitling, Stefan Dübel
Methods in Molecular Medicine|February 13, 2004
Cloning single-chain antibody fragments (scFv) from hybridoma cellsLars Toleikis, Olaf Broders, Stefan Dübel
Biotechnology & Genetic Engineering Reviews|March 5, 2004
Therapeutic antibodies and antibody fusion proteinsPetra Rohrbach, Olaf Broders, Lars Toleikis, et al.
Bioanalysis|May 1, 2020
Novel bioanalytical method for the characterization of the immune response directed against a bispecific F(ab) fragmentOlaf Broders, Uwe Wessels, Markus Zadak, et al.
Molecular Pharmaceutics|May 20, 2021
Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care FormatsPaulina Jakubiak, Rubén Alvarez-Sánchez, Matthias Fueth, et al.
Frontiers in Immunology|May 4, 2026
Translational strategy to support the first-in-human study of a TCR-like T cell bispecific with an <i>in vitro</i>-based safety approachAngelique Augustin, Blandine Avignon, Christophe Boetsch, et al.
Pageof 1